FI972862A - Uudet stafylokinaasijohdannaiset - Google Patents

Uudet stafylokinaasijohdannaiset Download PDF

Info

Publication number
FI972862A
FI972862A FI972862A FI972862A FI972862A FI 972862 A FI972862 A FI 972862A FI 972862 A FI972862 A FI 972862A FI 972862 A FI972862 A FI 972862A FI 972862 A FI972862 A FI 972862A
Authority
FI
Finland
Prior art keywords
dna fragment
directed mutagenesis
derivatives
plasmid
host cell
Prior art date
Application number
FI972862A
Other languages
English (en)
Swedish (sv)
Other versions
FI972862A0 (fi
Inventor
Desire Collen
Original Assignee
Leuven Res & Dev Vzw
Desire Collen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP95200023A external-priority patent/EP0721982A1/en
Priority claimed from EP95201531A external-priority patent/EP0721013B1/en
Application filed by Leuven Res & Dev Vzw, Desire Collen filed Critical Leuven Res & Dev Vzw
Publication of FI972862A0 publication Critical patent/FI972862A0/fi
Publication of FI972862A publication Critical patent/FI972862A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI972862A 1995-01-06 1997-07-04 Uudet stafylokinaasijohdannaiset FI972862A (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
EP95200023A EP0721982A1 (en) 1995-01-06 1995-01-06 New staphylokinase derivatives
US08/371,505 US5695754A (en) 1995-01-06 1995-01-11 Staphylokinase derivatives
EP95201531A EP0721013B1 (en) 1995-01-06 1995-06-09 New staphylokinase derivatives
US49909295A 1995-07-06 1995-07-06
JP7299781A JPH08289790A (ja) 1995-01-06 1995-11-17 新規なスタフィロキナーゼ誘導体
PCT/EP1996/000081 WO1996021016A2 (en) 1995-01-06 1996-01-03 New staphylokinase derivatives

Publications (2)

Publication Number Publication Date
FI972862A0 FI972862A0 (fi) 1997-07-04
FI972862A true FI972862A (fi) 1997-09-03

Family

ID=27514236

Family Applications (1)

Application Number Title Priority Date Filing Date
FI972862A FI972862A (fi) 1995-01-06 1997-07-04 Uudet stafylokinaasijohdannaiset

Country Status (22)

Country Link
EP (1) EP0793723B1 (fi)
JP (1) JPH08289790A (fi)
CN (1) CN1154729C (fi)
AT (1) ATE306550T1 (fi)
AU (1) AU705119B2 (fi)
BG (1) BG64344B1 (fi)
BR (1) BR9606724A (fi)
CA (1) CA2206479A1 (fi)
CZ (1) CZ290685B6 (fi)
DE (1) DE69635269T2 (fi)
EA (1) EA000121B1 (fi)
EE (1) EE9700150A (fi)
ES (1) ES2248805T3 (fi)
FI (1) FI972862A (fi)
HU (1) HUP9802915A3 (fi)
NO (1) NO973083L (fi)
NZ (1) NZ298801A (fi)
PL (1) PL184348B1 (fi)
RO (1) RO116969B1 (fi)
SK (1) SK89297A3 (fi)
TR (1) TR199700600T1 (fi)
WO (1) WO1996021016A2 (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5951980A (en) * 1995-01-06 1999-09-14 Leuven Research & Development Vzw Identification, production and use of new staphylokinase derivatives with reduced immunogenicity
ATE390441T1 (de) * 1998-10-30 2008-04-15 Novozymes As Niedrigallergene proteinvarianten
US6686164B1 (en) 1998-10-30 2004-02-03 Novozymes A/S Low allergenic protein variants
CN100342007C (zh) * 2000-01-28 2007-10-10 复旦大学 一种新型重组葡激酶及其制备方法
US6673580B2 (en) 2000-10-27 2004-01-06 Genentech, Inc. Identification and modification of immunodominant epitopes in polypeptides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0621899B1 (de) * 1991-12-30 1996-06-19 Medac Gesellschaft für klinische Spezialpräparate mbH Expression signalpeptid-freier staphylokinasen

Also Published As

Publication number Publication date
BG101556A (en) 1998-02-27
CN1168156A (zh) 1997-12-17
EE9700150A (et) 1997-12-15
SK89297A3 (en) 1998-05-06
WO1996021016A2 (en) 1996-07-11
EP0793723A2 (en) 1997-09-10
EA000121B1 (ru) 1998-08-27
CZ290685B6 (cs) 2002-09-11
CA2206479A1 (en) 1996-07-11
HUP9802915A2 (hu) 1999-03-29
CZ210497A3 (en) 1997-11-12
BG64344B1 (bg) 2004-10-29
NZ298801A (en) 2000-01-28
PL184348B1 (pl) 2002-10-31
AU705119B2 (en) 1999-05-13
PL321181A1 (en) 1997-11-24
ES2248805T3 (es) 2006-03-16
DE69635269T2 (de) 2006-06-14
CN1154729C (zh) 2004-06-23
JPH08289790A (ja) 1996-11-05
AU4437796A (en) 1996-07-24
EP0793723B1 (en) 2005-10-12
HUP9802915A3 (en) 2001-02-28
NO973083L (no) 1997-08-04
WO1996021016A3 (en) 1996-09-12
EA199700073A1 (ru) 1997-12-30
NO973083D0 (no) 1997-07-02
MX9705041A (es) 1998-07-31
RO116969B1 (ro) 2001-08-30
DE69635269D1 (de) 2006-02-23
ATE306550T1 (de) 2005-10-15
BR9606724A (pt) 1998-01-13
TR199700600T1 (xx) 1998-01-21
FI972862A0 (fi) 1997-07-04

Similar Documents

Publication Publication Date Title
Takagi et al. Control of folding of proteins secreted by a high expression secretion vector, pIN-III-ompA: 16-fold increase in production of active subtilisin E in Escherichia coli
US5100784A (en) Process for the preparation of mature human serum albumin
US5496924A (en) Fusion protein comprising an interleukin-2 fragment ballast portion
IE863334L (en) Fusion proteins with a eukaryotic ballast portion
Svendsen et al. The primary structure of the glutamic acid-specific protease ofStreptomyces griseus
JPH04166085A (ja) 新規プロテアーゼ
EP0797671B1 (en) A process of producing extracellular proteins in bacteria
JPH03228682A (ja) Ｅ．コリでの非融合タンパク質の調製方法
WO1999040198A3 (en) Identification, production and use of staphylokinase derivatives with reduced immunogenicity and/or reduced clearance
JPS6420095A (en) Polypeptide having anti-blood coagulating action
FI972862A (fi) Uudet stafylokinaasijohdannaiset
EP0528686B8 (en) Process for producing peptides
JPH04228086A (ja) ストレプトミセスにおける外来タン白質の製造法
EP1169461B1 (de) Verwendung von pankreatischer Procarboxypeptidase B zur Herstellung von Insulin
JP2637392B2 (ja) 遺伝子操作による生物活性β−ＮＧＦの生産方法
DK173380B1 (da) Præparat med mitogenisk aktivitet over for menneskeforhuds-fibroblaster, fremgangsmåde til fremstilling af en human, basisk
EP0352387A1 (en) Method for preparing a hirudin
RU2143492C1 (ru) Рекомбинантная плазмида, кодирующая гибридный белок - предшественник инсулина человека (варианты), штамм бактерий e.coli - продуцент гибридного белка - предшественника инсулина человека (варианты), способ получения инсулина человека
DE3900770A1 (de) Verfahren zur herstellung von pdgf-a und pdgf-aa
Ribó et al. Production of Human Pancreatic Ribonuclease inSaccharomyces cerevisiaeandEscherichia coli
IE902832A1 (en) Dna fragment containing at least one protease gene, a¹cloning vector containing such a dna fragment, a host cell¹transformed with a cloning vector constructed in this¹manner, and also the proteases produced by, or products such¹as foodstuffs prepared with, such host cells
RU2144082C1 (ru) Рекомбинантная плазмида, кодирующая гибридный белок-предшественник инсулина человека (варианты), штамм бактерий e.coli - продуцент гибридного белка-предшественника инсулина человека (варианты) и способ получения инсулина человека
Giga-Hama Secretion of human interleukin-6 using the P-factor secretion signal in Schizosaccharomyces pombe
Goochee et al. The effect of oligosaccharides on glycoprotein stability
JPH02219570A (ja) ヒト５―リポキシゲナーゼの製造方法

Legal Events

Date Code Title Description
MA Patent expired